Related Experiment Video
Updated: Jul 27, 2025
Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Published on: August 27, 2021
Sexual dimorphism in melanocyte stem cell behavior reveals combinational therapeutic strategies for cutaneous
Luye An1, Dahihm Kim1, Leanne Donahue1
1Department of Biomedical Sciences, Cornell University, Ithaca, NY, USA, 14850.
Abstract:
Vitiligo is an autoimmune skin disease caused by cutaneous melanocyte loss. Although phototherapy and T cell suppression therapy have been widely used to induce epidermal repigmentation, full pigmentation recovery is rarely achieved due to our poor understanding of the cellular and molecular mechanisms governing this process. Here, we identify unique melanocyte stem cell (McSC) epidermal migration rates between male and female mice, which is due to sexually dimorphic cutaneous inflammatory responses generated by ultra-violet B exposure. Using genetically engineered mouse models, and unbiased bulk and single-cell mRNA sequencing approaches, we determine that manipulating the inflammatory response through cyclooxygenase and its downstream prostaglandin product regulates McSC proliferation and epidermal migration in response to UVB exposure. Furthermore, we demonstrate that a combinational therapy that manipulates both macrophages and T cells (or innate and adaptive immunity) significantly promotes epidermal melanocyte re-population. With these findings, we propose a novel therapeutic strategy for repigmentation in patients with depigmentation conditions such as vitiligo.
Insights
Researchers discovered that manipulating inflammatory responses and combining innate and adaptive immunity therapies can significantly boost melanocyte repopulation, offering a new strategy for vitiligo treatment.
Area of Science:
- Dermatology and Immunology
- Stem Cell Biology
- Molecular Mechanisms of Skin Homeostasis
Background:
- Vitiligo, an autoimmune skin disease, involves melanocyte loss, with current therapies like phototherapy and T cell suppression offering limited repigmentation due to poorly understood mechanisms.
- Effective strategies for vitiligo treatment are hindered by incomplete knowledge of the cellular and molecular processes governing epidermal repigmentation.
Approach:
- Investigated sex-specific differences in melanocyte stem cell (McSC) epidermal migration rates in mice following ultraviolet B (UVB) exposure.
- Employed genetically engineered mouse models and bulk/single-cell mRNA sequencing to analyze UVB-induced inflammatory responses.
- Examined the role of cyclooxygenase and prostaglandin pathways in regulating McSC proliferation and migration.
Key Points:
- Identified sexually dimorphic inflammatory responses to UVB exposure affecting McSC epidermal migration.
- Demonstrated that modulating cyclooxygenase and prostaglandin pathways influences McSC behavior in response to UVB.
- Showcased that a combination therapy targeting macrophages and T cells (innate and adaptive immunity) significantly enhances epidermal melanocyte repopulation.
Conclusions:
- The study reveals novel insights into the regulation of melanocyte stem cell migration and proliferation.
- Proposes a new therapeutic approach for vitiligo and other depigmentation disorders by manipulating inflammatory pathways and immune cell interactions.
- Highlights the potential of combined innate and adaptive immunity modulation for promoting skin repigmentation.
Related Concept Videos
01:22iPS Cell Differentiation
01:06Multipotency and Niche of Bulge Stem Cell
01:28Forced Transdifferentiation
Artificial...
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...